Histone deacetylase inhibitors globally enhance h3/h4 tail acetylation without affecting h3 lysine 56 acetylation.

PubWeight™: 1.11‹?› | Rank: Top 10%

🔗 View Article (PMC 3256565)

Published in Sci Rep on January 12, 2012

Authors

Paul Drogaris, Valérie Villeneuve, Christelle Pomiès, Eun-Hye Lee, Véronique Bourdeau, Eric Bonneil, Gerardo Ferbeyre, Alain Verreault, Pierre Thibault

Articles citing this

Genetic code expansion in stable cell lines enables encoded chromatin modification. Nat Methods (2016) 1.50

Quantitative proteomic analysis of histone modifications. Chem Rev (2015) 1.32

Measurement of acetylation turnover at distinct lysines in human histones identifies long-lived acetylation sites. Nat Commun (2013) 1.06

Scratching the (lateral) surface of chromatin regulation by histone modifications. Nat Struct Mol Biol (2013) 1.05

Inhibition of histone deacetylase 3 causes replication stress in cutaneous T cell lymphoma. PLoS One (2013) 0.93

Chaperone-mediated acetylation of histones by Rtt109 identified by quantitative proteomics. J Proteomics (2012) 0.86

HDAC 3-selective inhibitor RGFP966 demonstrates anti-inflammatory properties in RAW 264.7 macrophages and mouse precision-cut lung slices by attenuating NF-κB p65 transcriptional activity. Biochem Pharmacol (2016) 0.81

Histone-modifying enzymes, histone modifications and histone chaperones in nucleosome assembly: Lessons learned from Rtt109 histone acetyltransferases. Crit Rev Biochem Mol Biol (2014) 0.80

Radiation-induced alterations in histone modification patterns and their potential impact on short-term radiation effects. Front Oncol (2012) 0.79

Protein target quantification decision tree. Int J Proteomics (2013) 0.79

Interplay between histone H3 lysine 56 deacetylation and chromatin modifiers in response to DNA damage. Genetics (2015) 0.78

Sites of acetylation on newly synthesized histone H4 are required for chromatin assembly and DNA damage response signaling. Mol Cell Biol (2013) 0.78

A small molecule inhibitor of fungal histone acetyltransferase Rtt109. Bioorg Med Chem Lett (2013) 0.78

Chromatin dynamics during DNA replication. Genome Res (2016) 0.78

The histone acetyltransferase p300 inhibitor C646 reduces pro-inflammatory gene expression and inhibits histone deacetylases. Biochem Pharmacol (2015) 0.77

Quantification of histone modifications using ¹⁵N metabolic labeling. Methods (2013) 0.77

Progress in epigenetic histone modification analysis by mass spectrometry for clinical investigations. Expert Rev Proteomics (2015) 0.77

Mutations that prevent or mimic persistent post-translational modifications of the histone H3 globular domain cause lethality and growth defects in Drosophila. Epigenetics Chromatin (2016) 0.76

Cell cycle-dependent changes in H3K56ac in human cells. Cell Cycle (2015) 0.76

HDAC expression and activity is upregulated in diseased lupus-prone mice. Int Immunopharmacol (2015) 0.76

HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory Diseases. Biomed Res Int (2016) 0.75

The Commercial Antibodies Widely Used to Measure H3 K56 Acetylation Are Non-Specific in Human and Drosophila Cells. PLoS One (2016) 0.75

Adipocytes promote malignant growth of breast tumours with monocarboxylate transporter 2 expression via β-hydroxybutyrate. Nat Commun (2017) 0.75

Site-specific quantification of lysine acetylation in the N-terminal tail of histone H4 using a double-labelling, targeted UHPLC MS/MS approach. Anal Bioanal Chem (2016) 0.75

Quantitative Measurement of Histone Tail Acetylation Reveals Stage-Specific Regulation and Response to Environmental Changes during Drosophila Development. Biochemistry (2016) 0.75

Development of novel cellular histone-binding and chromatin-displacement assays for bromodomain drug discovery. Epigenetics Chromatin (2015) 0.75

Bivalent Epigenetic Control of Oncofetal Gene Expression in Cancer. Mol Cell Biol (2017) 0.75

Site-specific azide-acetyllysine photochemistry on epigenetic readers for interactome profiling. Chem Sci (2017) 0.75

Articles cited by this

Chromatin modifications and their function. Cell (2007) 55.98

The language of covalent histone modifications. Nature (2000) 44.92

Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov (2006) 14.01

Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J Biol Chem (1990) 9.21

Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet (2005) 8.45

Solvent mediated interactions in the structure of the nucleosome core particle at 1.9 a resolution. J Mol Biol (2002) 8.42

Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat Rev Drug Discov (2002) 6.97

Dot1p modulates silencing in yeast by methylation of the nucleosome core. Cell (2002) 6.29

Nucleosome assembly by a complex of CAF-1 and acetylated histones H3/H4. Cell (1996) 5.77

A role for cell-cycle-regulated histone H3 lysine 56 acetylation in the DNA damage response. Nature (2005) 5.13

FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma. Oncologist (2007) 4.95

Histone deacetylase inhibitors: overview and perspectives. Mol Cancer Res (2007) 4.91

CBP/p300-mediated acetylation of histone H3 on lysine 56. Nature (2009) 4.83

Reconstitution of nucleosome core particles from recombinant histones and DNA. Methods Enzymol (2004) 4.57

Conservation of deposition-related acetylation sites in newly synthesized histones H3 and H4. Proc Natl Acad Sci U S A (1995) 4.26

Decision tree-driven tandem mass spectrometry for shotgun proteomics. Nat Methods (2008) 3.53

The sirtuins hst3 and Hst4p preserve genome integrity by controlling histone h3 lysine 56 deacetylation. Curr Biol (2006) 3.37

Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining. Nat Struct Mol Biol (2010) 3.27

The human and mouse replication-dependent histone genes. Genomics (2002) 3.23

PTMs on H3 variants before chromatin assembly potentiate their final epigenetic state. Mol Cell (2006) 3.20

Screen for DNA-damage-responsive histone modifications identifies H3K9Ac and H3K56Ac in human cells. EMBO J (2009) 2.98

Histone H3-K56 acetylation is important for genomic stability in mammals. Cell Cycle (2009) 2.77

Clinical studies of histone deacetylase inhibitors. Clin Cancer Res (2009) 2.68

Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer. Prostate (2004) 2.49

Histone h3 lysine 56 acetylation is linked to the core transcriptional network in human embryonic stem cells. Mol Cell (2009) 2.27

Cell cycle-dependent deacetylation of telomeric histone H3 lysine K56 by human SIRT6. Cell Cycle (2009) 2.22

Rational combinations using HDAC inhibitors. Clin Cancer Res (2009) 2.12

Dynamic nucleosomes. Chromosome Res (2006) 1.93

Dynamics of histone acetylation in vivo. A function for acetylation turnover? Biochem Cell Biol (2002) 1.83

Neural sirtuin 6 (Sirt6) ablation attenuates somatic growth and causes obesity. Proc Natl Acad Sci U S A (2010) 1.49

Histone deacetylases: a common molecular target for differentiation treatment of acute myeloid leukemias? Oncogene (2001) 1.47

HDAC inhibitor-based therapies and haematological malignancy. Ann Oncol (2009) 1.45

Histone H4 lysine 91 acetylation a core domain modification associated with chromatin assembly. Mol Cell (2005) 1.45

Histone deacetylase inhibitors in cancer therapy. Curr Opin Oncol (2008) 1.44

Distinct pharmacological properties of second generation HDAC inhibitors with the benzamide or hydroxamate head group. Int J Cancer (2007) 1.43

Modifications of H3 and H4 during chromatin replication, nucleosome assembly, and histone exchange. J Biol Chem (2006) 1.42

An Nalpha-acetyltransferase responsible for acetylation of the N-terminal residues of histones H4 and H2A. J Biol Chem (2003) 1.36

Genome-wide profiling of H3K56 acetylation and transcription factor binding sites in human adipocytes. PLoS One (2011) 1.34

p300-mediated acetylation of histone H3 lysine 56 functions in DNA damage response in mammals. J Biol Chem (2010) 1.34

Biomarkers for predicting clinical responses to HDAC inhibitors. Cancer Lett (2009) 1.31

Romidepsin for the treatment of cutaneous T-cell lymphoma. Drugs Today (Barc) (2009) 1.19

Intact mass detection, interpretation, and visualization to automate Top-Down proteomics on a large scale. Proteomics (2010) 1.16

Resazurin assay of radiation response in cultured cells. Br J Radiol (2005) 1.12

The type III histone deacetylase Sirt1 protein suppresses p300-mediated histone H3 lysine 56 acetylation at Bclaf1 promoter to inhibit T cell activation. J Biol Chem (2011) 1.11

Comprehensive profiling of histone modifications using a label-free approach and its applications in determining structure-function relationships. Anal Chem (2008) 1.07

Epigenetic and replacement roles of histone variant H3.3 in reproduction and development. Int J Dev Biol (2009) 0.99

Chromatin structure and dynamics: functional implications. Biochimie (2002) 0.99

ASF1A and ATM regulate H3K56-mediated cell-cycle checkpoint recovery in response to UV irradiation. Nucleic Acids Res (2011) 0.98

DNA damage in the presence of chemical genotoxic agents induce acetylation of H3K56 and H4K16 but not H3K9 in mammalian cells. Mol Biol Rep (2011) 0.89

And-1 is required for the stability of histone acetyltransferase Gcn5. Oncogene (2011) 0.87

ABRF-PRG07: advanced quantitative proteomics study. J Biomol Tech (2011) 0.85

Efficient readout of posttranslational codes on the 50-residue tail of histone H3 by high-resolution MS/MS. Anal Biochem (2009) 0.84

Differential sensitivity of human leukemic cell lines to the histone deacetylase inhibitor, trichostatin A. Leuk Res (2009) 0.79

Articles by these authors

Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol (2004) 6.35

Chromatin challenges during DNA replication and repair. Cell (2007) 5.23

An E2F/miR-20a autoregulatory feedback loop. J Biol Chem (2006) 5.20

A role for cell-cycle-regulated histone H3 lysine 56 acetylation in the DNA damage response. Nature (2005) 5.13

The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence. Genes Dev (2007) 4.91

Phagosomes are competent organelles for antigen cross-presentation. Nature (2003) 3.97

Acetylation of histone H3 lysine 56 regulates replication-coupled nucleosome assembly. Cell (2008) 3.96

A Rad53 kinase-dependent surveillance mechanism that regulates histone protein levels in S. cerevisiae. Cell (2003) 3.72

Ptychographic X-ray computed tomography at the nanoscale. Nature (2010) 3.52

The sirtuins hst3 and Hst4p preserve genome integrity by controlling histone h3 lysine 56 deacetylation. Curr Biol (2006) 3.37

Biological imaging by soft x-ray diffraction microscopy. Proc Natl Acad Sci U S A (2005) 2.79

Structural basis of HP1/PXVXL motif peptide interactions and HP1 localisation to heterochromatin. EMBO J (2004) 2.79

Modulation of heterochromatin protein 1 dynamics in primary Mammalian cells. Science (2003) 2.61

Oncogenic MAPK signaling stimulates mTORC1 activity by promoting RSK-mediated raptor phosphorylation. Curr Biol (2008) 2.58

PML is a direct p53 target that modulates p53 effector functions. Mol Cell (2004) 2.40

Changes in flagellin glycosylation affect Campylobacter autoagglutination and virulence. Mol Microbiol (2006) 2.11

Metformin reduces endogenous reactive oxygen species and associated DNA damage. Cancer Prev Res (Phila) (2012) 2.10

The Mycobacterium tuberculosis regulatory network and hypoxia. Nature (2013) 2.04

Polo kinase regulates mitotic chromosome condensation by hyperactivation of condensin DNA supercoiling activity. Mol Cell (2009) 2.03

Structural basis for the recognition of histone H4 by the histone-chaperone RbAp46. Structure (2008) 1.98

The phagosomal proteome in interferon-gamma-activated macrophages. Immunity (2009) 1.95

Fungal Rtt109 histone acetyltransferase is an unexpected structural homolog of metazoan p300/CBP. Nat Struct Mol Biol (2008) 1.89

aPKC-mediated phosphorylation regulates asymmetric membrane localization of the cell fate determinant Numb. EMBO J (2007) 1.81

MHC I-associated peptides preferentially derive from transcripts bearing miRNA response elements. Blood (2012) 1.79

DNA damage signaling and p53-dependent senescence after prolonged beta-interferon stimulation. Mol Biol Cell (2006) 1.78

Quantitative biological imaging by ptychographic x-ray diffraction microscopy. Proc Natl Acad Sci U S A (2009) 1.78

ERK1/2 phosphorylate Raptor to promote Ras-dependent activation of mTOR complex 1 (mTORC1). J Biol Chem (2010) 1.74

Modulation of histone H3 lysine 56 acetylation as an antifungal therapeutic strategy. Nat Med (2010) 1.69

Regulation of histone H3 lysine 56 acetylation in Schizosaccharomyces pombe. J Biol Chem (2007) 1.65

ETO2 coordinates cellular proliferation and differentiation during erythropoiesis. EMBO J (2006) 1.63

Mitochondrial dysfunction contributes to oncogene-induced senescence. Mol Cell Biol (2009) 1.61

Improvement in peptide detection for proteomics analyses using NanoLC-MS and high-field asymmetry waveform ion mobility mass spectrometry. Anal Chem (2005) 1.60

Structural heterogeneity of carbohydrate modifications affects serospecificity of Campylobacter flagellins. Mol Microbiol (2002) 1.58

Histone H3 lysine 56 acetylation: a new twist in the chromosome cycle. Cell Cycle (2006) 1.46

The exon junction complex controls the splicing of MAPK and other long intron-containing transcripts in Drosophila. Cell (2010) 1.44

H3 lysine 4 is acetylated at active gene promoters and is regulated by H3 lysine 4 methylation. PLoS Genet (2011) 1.43

DNA base excision repair of uracil residues in reconstituted nucleosome core particles. EMBO J (2002) 1.42

N-Terminal ubiquitination of extracellular signal-regulated kinase 3 and p21 directs their degradation by the proteasome. Mol Cell Biol (2004) 1.40

Regulation of GREB1 transcription by estrogen receptor alpha through a multipartite enhancer spread over 20 kb of upstream flanking sequences. J Biol Chem (2007) 1.38

Diffractive imaging of nonperiodic materials with future coherent X-ray sources. J Synchrotron Radiat (2004) 1.37

ERKs in cancer: friends or foes? Cancer Res (2014) 1.37

Regulation of histone synthesis and nucleosome assembly. Biochimie (2005) 1.36

Identification of unusual bacterial glycosylation by tandem mass spectrometry analyses of intact proteins. Anal Chem (2005) 1.34

A novel proteomics approach to identify SUMOylated proteins and their modification sites in human cells. Mol Cell Proteomics (2010) 1.34

The MHC class I peptide repertoire is molded by the transcriptome. J Exp Med (2008) 1.31

Organelle proteomics: looking at less to see more. Trends Cell Biol (2003) 1.30

Identification of hammerhead ribozymes in all domains of life reveals novel structural variations. PLoS Comput Biol (2011) 1.29

MYST protein acetyltransferase activity requires active site lysine autoacetylation. EMBO J (2011) 1.29

The DNA damage signaling pathway connects oncogenic stress to cellular senescence. Cell Cycle (2007) 1.28

Regulation of chronological aging in Schizosaccharomyces pombe by the protein kinases Pka1 and Sck2. Aging Cell (2006) 1.26

Regulation of E2Fs and senescence by PML nuclear bodies. Genes Dev (2011) 1.25

Histone H3 lysine 4 mono-methylation does not require ubiquitination of histone H2B. J Mol Biol (2005) 1.25

Oligodendrocyte-myelin glycoprotein (OMgp) is an inhibitor of neurite outgrowth. J Neurochem (2002) 1.24

The emergence of regulated histone proteolysis. Curr Opin Genet Dev (2006) 1.24

Process outgrowth in oligodendrocytes is mediated by CNP, a novel microtubule assembly myelin protein. J Cell Biol (2005) 1.24

RNA silencing of checkpoint regulators sensitizes p53-defective prostate cancer cells to chemotherapy while sparing normal cells. Cancer Res (2005) 1.23

Molecular dissection of the eukaryotic initiation factor 4E (eIF4E) export-competent RNP. EMBO J (2009) 1.21

Phosphorylation of IRF-3 on Ser 339 generates a hyperactive form of IRF-3 through regulation of dimerization and CBP association. J Virol (2008) 1.19

Human fibroblasts require the Rb family of tumor suppressors, but not p53, for PML-induced senescence. Oncogene (2004) 1.19

Activin/TGF-beta induce apoptosis through Smad-dependent expression of the lipid phosphatase SHIP. Nat Cell Biol (2002) 1.19

Nck-dependent activation of extracellular signal-regulated kinase-1 and regulation of cell survival during endoplasmic reticulum stress. Mol Biol Cell (2004) 1.19

Identification of differentially expressed proteins in human glioblastoma cell lines and tumors. Glia (2003) 1.19

Pro-aging effects of glucose signaling through a G protein-coupled glucose receptor in fission yeast. PLoS Genet (2009) 1.19

SOCS1 links cytokine signaling to p53 and senescence. Mol Cell (2009) 1.18

Tumor suppressor activity of the ERK/MAPK pathway by promoting selective protein degradation. Genes Dev (2013) 1.18

Enhanced sensitivity in proteomics experiments using FAIMS coupled with a hybrid linear ion trap/Orbitrap mass spectrometer. J Proteome Res (2009) 1.17

Maintenance DNA methylation of nucleosome core particles. J Biol Chem (2003) 1.17

Regulation of the DNA damage response and gene expression by the Dot1L histone methyltransferase and the 53Bp1 tumour suppressor. PLoS One (2011) 1.16

Histone H3 K56 hyperacetylation perturbs replisomes and causes DNA damage. Genetics (2008) 1.16

PEA-15 is inhibited by adenovirus E1A and plays a role in ERK nuclear export and Ras-induced senescence. J Biol Chem (2004) 1.15

Modulation of the phagosome proteome by interferon-gamma. Mol Cell Proteomics (2007) 1.15

Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK/NF-κB activation. Aging Cell (2013) 1.13

Glycopeptide specificity of the secretory protein folding sensor UDP-glucose glycoprotein:glucosyltransferase. EMBO Rep (2003) 1.13

The price of tumour suppression? Nature (2002) 1.10